Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
about
Natural Compounds from Saffron and Bear Bile Prevent Vision Loss and Retinal DegenerationPhotoreceptors in diabetic retinopathyMicrovascular complications and diabetic retinopathy: recent advances and future implicationsRedox balance dynamically regulates vascular growth and remodelingEffects of curcumin on retinal oxidative stress and inflammation in diabetesGlutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathyCYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expressionOcular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic ratsTranscriptome analysis using next generation sequencing reveals molecular signatures of diabetic retinopathy and efficacy of candidate drugsTherapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways.Calcium mediates high glucose-induced HIF-1α and VEGF expression in cultured rat retinal Müller cells through CaMKII-CREB pathway.Involvement of Nrf2 in Ocular Diseases.Vascular dysfunction in retinopathy-an emerging role for arginaseOxygen delivery, consumption, and conversion to reactive oxygen species in experimental models of diabetic retinopathyModulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon.Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction.Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives.Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivator 1alphaRole of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression.Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.Mitochondrial dysfunction in retinal diseasesEpigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathyChoosing preclinical study models of diabetic retinopathy: key problems for considerationA metabolomic study on the effect of intravascular laser blood irradiation on type 2 diabetic patients.Global metabolomic and isobaric tagging capillary liquid chromatography-tandem mass spectrometry approaches for uncovering pathway dysfunction in diabetic mouse aorta.Novel drugs and their targets in the potential treatment of diabetic retinopathy.Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy.Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathyLipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathyNovel role of mitochondrial matrix metalloproteinase-2 in the development of diabetic retinopathyOcular complications of diabetes mellitus.Neurovascular interaction and the pathophysiology of diabetic retinopathyOrgan specific optical imaging of mitochondrial redox state in a rodent model of hereditary hemorrhagic telangiectasia-1NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice.Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.Mitochondrial biogenesis and the development of diabetic retinopathyHigh-Fat Diet-Induced Retinal Dysfunction.
P2860
Q26799250-703B9F48-3C33-4076-8A73-95B9F0884508Q26801918-49B62F05-5AF3-41C1-AA8F-6D2A811B5BA6Q26822476-19C1D08A-6996-45D5-9BAE-481FD83627CBQ27004547-EE54C370-4A3B-4C8B-97DA-A5385ABB0CAFQ28567589-098CFBD6-BB87-4369-ADAA-04D42FF420CAQ28584054-17F06FA4-2AC2-49FF-8DED-BE5DB9E73E63Q28592244-C580EF20-8E1D-4465-89B8-250EEB620A6DQ28730878-23A91769-6921-45D8-8EA3-59C1A1E3BC1DQ30010106-1A0DFB3E-37A4-41E9-93AB-4F2204057EEFQ31146840-A8950EF7-887B-46CC-A36B-23D0CC655394Q33571261-855B008C-2288-43DA-A4F0-4E454C9494C2Q33573617-B0CF3A11-CF65-4DA5-A1A7-FFBF1A8D2736Q33625727-C561E705-2720-4E11-B6B5-1D0B4354192CQ33737370-5D52D77D-2F90-4601-A22D-D9DE579E22A1Q33867982-95DC5FBF-7F0A-4B65-956A-785E114325BAQ34009114-C3668148-6C0B-4463-A68E-E63717268E75Q34077433-0C08670D-8A28-47C0-B9DF-59A7E0C8EB83Q34081378-31E0A1CD-449F-4C59-99D9-FB83D033922EQ34081808-74909E90-D21B-4A10-B2BA-12BD0040C667Q34082901-7F046167-886A-4CE9-9C30-FBF6B1D3A2FCQ34110092-46AFE944-6551-4543-8ABF-31549069B2F9Q34159652-F5CDD1F6-87AD-4533-94A3-867F0F62084FQ34221905-98EB1EDF-4F14-4AA5-9F5C-953F0A3D3D42Q34511162-55EF5EE8-3952-4BB6-A5BC-40ED6932A500Q34564352-B0156130-A20F-4E0F-9930-1674A64D6CF4Q34566101-6F2A8B34-263E-4873-B8EA-79A8E8D84DF2Q34669606-6FA2A1E2-ACF7-40FF-99ED-6349D60DFDADQ34688209-352B6276-C64F-4FD0-B43E-4CE249C931BAQ34718901-260AD097-CCE7-48BC-8023-55026C398679Q34950714-B6FC2A9E-BC55-4A20-91BA-6669B5ACFE56Q35012473-F75EADA4-0FF7-43A2-84C4-305AE540C033Q35027703-50014EE9-0EEB-4D45-897E-D7C14F080D66Q35049903-C686FC26-A5E7-49C5-A1FA-9941B8912873Q35071239-BF7B43E2-F103-4877-A87F-16DD2D6E70D3Q35072955-78AF0F6A-3289-4B80-886A-C559D752115DQ35188001-D84F3F10-3E02-4301-B87C-42E510637932Q35247687-A6EEF039-04B2-4B51-9942-07A917F1C46EQ35404674-63C582F5-336C-4166-AC77-35CDB076FF35Q35457777-9BF2C1CE-4663-43B7-BF37-CC5C26DE93A0Q35531717-DF1BBFC7-95EC-408A-AF76-015EF0751966
P2860
Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Abnormalities of retinal metab ...... he development of retinopathy.
@en
Abnormalities of retinal metab ...... he development of retinopathy.
@nl
type
label
Abnormalities of retinal metab ...... he development of retinopathy.
@en
Abnormalities of retinal metab ...... he development of retinopathy.
@nl
prefLabel
Abnormalities of retinal metab ...... he development of retinopathy.
@en
Abnormalities of retinal metab ...... he development of retinopathy.
@nl
P2093
P1433
P1476
Abnormalities of retinal metab ...... he development of retinopathy.
@en
P2093
P304
P356
10.2337/DIABETES.50.8.1938
P407
P577
2001-08-01T00:00:00Z